RHOT1 - Mitochondrial Rho GTPase 1

RHOT1 - Mitochondrial Rho GTPase 1

Introduction

Rhot1 Mitochondrial Rho Gtpase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@nguyen2014]
<h3>RHOT1</h3> [@wang2011]
<table> [@macaskill2010]
<tr><th>Full Name</th><td>Mitochondrial Rho GTPase 1 (MIRO1)</td></tr>
<tr><th>Chromosome</th><td>10q21.3</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/55288" target="_blank">55288</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/614161" target="_blank">614161</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000153823" target="_blank">ENSG00000153823</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q8IXI1" target="_blank">Q8IXI1</a></td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Hereditary Spastic Paraplegia, Alzheimer's Disease, Mitochondrial Disorders, Peripheral Neuropathy</td></tr>
</table>
</div>

Pathway Diagram

RHOT1 - Mitochondrial Rho GTPase 1

Introduction

Rhot1 Mitochondrial Rho Gtpase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@nguyen2014]
<h3>RHOT1</h3> [@wang2011]
<table> [@macaskill2010]
<tr><th>Full Name</th><td>Mitochondrial Rho GTPase 1 (MIRO1)</td></tr>
<tr><th>Chromosome</th><td>10q21.3</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/55288" target="_blank">55288</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/614161" target="_blank">614161</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000153823" target="_blank">ENSG00000153823</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q8IXI1" target="_blank">Q8IXI1</a></td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Hereditary Spastic Paraplegia, Alzheimer's Disease, Mitochondrial Disorders, Peripheral Neuropathy</td></tr>
</table>
</div>

Pathway Diagram

Overview

RHOT1 (Mitochondrial Rho GTPase 1), also known as MIRO1, encodes a unique calcium-binding GTPase that resides on the outer mitochondrial membrane and serves as a master regulator of mitochondrial dynamics, trafficking, and quality control. MIRO1 is a 618-amino acid protein that integrates cellular energy status, calcium signaling, and mitochondrial quality control through its interactions with molecular motor proteins and the autophagy machinery.

The MIRO1 protein sits at the interface between mitochondrial dynamics and intracellular transport. It contains two EF-hand calcium-binding domains that sense cytosolic calcium concentrations, allowing rapid arrest of mitochondrial movement during periods of high neuronal activity. This calcium-dependent "stop" signal ensures that mitochondria pause at energy-demanding synapses where ATP supply is critically needed. Mutations in RHOT1 cause autosomal recessive hereditary spastic paraplegia (HSP) and have been implicated in Parkinson's disease susceptibility, highlighting the critical importance of mitochondrial transport for neuronal health.

Function

Molecular Function

RHOT1 encodes a protein with unique dual enzymatic and adapter functions:

1. Calcium-Dependent GTPase Activity:

• MIRO1 hydrolyzes GTP to GDP, regulated by calcium binding to EF-hand domains
• Calcium influx through [NMDA](/entities/nmda-receptor) receptors or voltage-gated calcium channels activates MIRO1
• GTP-bound MIRO1 promotes mitochondrial motility; GDP-bound form halts movement
• The GTPase domain (approximately residues 1-300) shares homology with Rho family GTPases

• MIRO1 directly interacts with Milton (also known as TRAK1/2) adaptor proteins
• Milton links MIRO1 to kinesin-1 heavy chain for anterograde transport
• The same complex can engage dynein for retrograde movement
• This tripartite complex (MIRO1-Milton-kinesin/dynein) enables long-range axonal transport

• MIRO1 coordinates mitophagy initiation by recruiting parkin to damaged mitochondria
• Upon mitochondrial depolarization, PINK1 phosphorylates MIRO1, enhancing parkin recruitment
• MIRO1 degradation by the proteasome occurs during mitophagy
• This pathway is critical for elimination of dysfunctional mitochondria in [neurons](/entities/neurons)

• MIRO1 influences mitochondrial morphology through interactions with fusion/fission machinery
• Coordinates mitochondrial fission events with transport
• Links mitochondrial trafficking to cellular metabolic state

Brain Expression

RHOT1 is expressed throughout the nervous system with particular enrichment in:

• Cerebral [cortex](/brain-regions/cortex) (all layers, especially layer V)
• [Hippocampus](/brain-regions/hippocampus) (CA1-CA3 pyramidal neurons, dentate granule cells)
• Basal ganglia (striatal medium spiny neurons, substantia nigra pars compacta)
• Cerebellum (Purkinje cells, granule cells)
• Spinal cord (motor neurons)
• Peripheral nervous system (sensory and motor neurons)

Disease Associations

Hereditary Spastic Paraplegia (HSP)

RHOT1 mutations cause autosomal recessive HSP, a disorder characterized by:

• Progressive lower limb spasticity and weakness
• Variable peripheral neuropathy
• Cognitive impairment in some cases

• p.Arg272Cys
• p.Arg372Trp
• p.Lys369Glu

Parkinson's Disease

Multiple connections between RHOT1 and PD:

• Genetic Link: RHOT1 variants associated with PD risk in genome-wide studies
• PINK1/Parkin Pathway: MIRO1 is a key substrate of PINK1 kinase
• [α-Synuclein](/proteins/alpha-synuclein) Toxicity: MIRO1 dysfunction exacerbates α-synuclein-induced mitochondrial defects
• LRRK2 Connection: LRRK2 mutations affect mitochondrial dynamics via MIRO1
• Dopaminergic Vulnerability: MIRO1 is essential for mitochondrial maintenance in SNc neurons

Alzheimer's Disease

RHOT1 dysfunction contributes to AD pathogenesis through:

• Synaptic Mitochondrial Depletion: Impaired transport reduces synaptic mitochondria
• Amyloid-β Toxicity: [Aβ](/proteins/amyloid-beta) directly impairs MIRO1 function
• [Tau](/proteins/tau) Pathology: [Tau](/proteins/tau) disrupts mitochondrial transport by displacing MIRO1 from microtubules
• Calcium Dysregulation: AD-associated calcium dysregulation disrupts MIRO1-mediated stopping

Other Neurodegenerative Conditions

• Amyotrophic Lateral Sclerosis: Mitochondrial transport defects in motor neurons
• Huntington's Disease: Mutant [huntingtin](/proteins/huntingtin-protein) disrupts MIRO1-Milton interaction
• Charcot-Marie-Tooth Disease: Peripheral neuropathy due to transport defects
• Peripheral Neuropathies: Axonal degeneration from mitochondrial dysfunction

Therapeutic Implications

Therapeutic Approaches

1. Gene Therapy:

• AAV-mediated RHOT1 wild-type expression for HSP
• CRISPR correction of pathogenic mutations
• RNA interference for gain-of-function variants (if applicable)

• Calcium channel blockers to reduce pathological calcium influx
• MIRO1 GTPase activity modulators
• Mitochondrial transport enhancers (notalozan, erythropoietin)

• Mitochondrial antioxidants (MitoQ, CoQ10)
• [Autophagy](/entities/autophagy) enhancers to compensate for quality control defects
• Metabolic supplements to support mitochondrial function

• Recombinant MIRO1 protein delivery
• Stabilizing compounds for mutant MIRO1

Challenges

• Balancing mitochondrial motility (too much movement can be detrimental)
• The calcium-sensing function must be preserved in any therapeutic
• Delivery to specific neuronal populations (CNS vs PNS)
• Mitophagy enhancement must be carefully controlled

Key Publications

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [RHOT1 Protein](/proteins/rhot1)
• [Mechanisms Index](/mechanisms)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• [Mitochondrial Transport](/mechanisms/mitochondrial-transport)
• [Mitophagy](/mechanisms/mitophagy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)

External Links

• [NCBI Gene: RHOT1](https://www.ncbi.nlm.nih.gov/gene/55288)
• [UniProt: RHOT1/MIRO1](https://www.uniprot.org/uniprot/Q8IXI1)
• [Ensembl: RHOT1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000153823)
• [OMIM: RHOT1](https://www.omim.org/entry/614161)
• [UCSC Genome Browser: RHOT1](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chr10:72300000-72400000)

Background

The study of Rhot1 Mitochondrial Rho Gtpase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy](/hypothesis/h-91bdb9ad) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: RHOT1

Pathway Diagram

The following diagram shows the key molecular relationships involving RHOT1 - Mitochondrial Rho GTPase 1 discovered through SciDEX knowledge graph analysis: